Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells von VON HAEFEN, Clarissa, WIEDER, Thomas, GILLISSEN, Bernd, STÄRCK, Lilian, GRAUPNER, Vilma, DÖRKEN, Bernd, DANIEL, Peter T

Volltext

IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel as 1L thera... von Jotte, Robert M., Cappuzzo, Federico, Vynnychenko, Ihor, Stroyakovskiy, Daniil, Rodriguez Abreu, Delvys, Hussein, Maen A., Soo, Ross A., Conter, Henry Jacob, Kozuki, Toshiyuki, Silva, Carlos, Graupner, Vilma, Sun, Shawn, Lin, Ray S, Kelsch, Claudia, Kowanetz, Marcin, Hoang, Tien, Sandler, Alan, Socinski, Mark A.

Volltext

Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53 von Graupner, Vilma, Schulze-Osthoff, Klaus, Essmann, Frank, Jänicke, Reiner U.

Volltext

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial von Jotte, Robert, Cappuzzo, Federico, Vynnychenko, Ihor, Stroyakovskiy, Daniil, Rodríguez-Abreu, Delvys, Hussein, Maen, Soo, Ross, Conter, Henry J., Kozuki, Toshiyuki, Huang, Kuan-Chieh, Graupner, Vilma, Sun, Shawn W., Hoang, Tien, Jessop, Helen, McCleland, Mark, Ballinger, Marcus, Sandler, Alan, Socinski, Mark A.

Volltext

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Prima... von Huober, Jens, Barrios, Carlos H., Niikura, Naoki, Jarząb, Michał, Chang, Yuan-Ching, Huggins-Puhalla, Shannon L., Pedrini, José, Zhukova, Lyudmila, Graupner, Vilma, Eiger, Daniel, Henschel, Volkmar, Gochitashvili, Nino, Lambertini, Chiara, Restuccia, Eleonora, Zhang, Hong

Volltext

Extension of the Alternative Intravenous Dosing Regimens of Atezolizumab into Combination Settings through Modeling and Simulation von Liu, Stephanie N., Marchand, Mathilde, Liu, Xiaoyan, Ingle, Gladys, Maiya, Vidya, Graupner, Vilma, Elze, Markus C., Chan, Phyllis, Hsu, Joy C., Lin, Alyse, Vadhavkar, Shweta, Wu, Benjamin, Bruno, Rene

Volltext

Extension of the Alternative IV Dosing Regimens of Atezolizumab into Combination Settings through Modeling and Simulation von Liu, Stephanie N, Marchand, Mathilde, Liu, Xiaoyan, Ingle, Gladys, Maiya, Vidya, Graupner, Vilma, Elze, Markus C, Chan, Phyllis, Hsu, Joy C, Lin, Alyse, Vadhavkar, Shweta, Wu, Benjamin, Bruno, Rene

Volltext

The do's and don'ts of p53 isoforms von Jänicke, Reiner U., Graupner, Vilma, Budach, Wilfried, Essmann, Frank

Volltext

Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway von Gillissen, Bernhard, Essmann, Frank, Graupner, Vilma, Stärck, Lilian, Radetzki, Silke, Dörken, Bernd, Schulze-Osthoff, Klaus, Daniel, Peter T.

Volltext

Differential regulation of the pro-apoptotic multidomain protein Bak by p53 and p73 at the promoter level von Schulze-Osthoff, Klaus, Graupner, Vilma, Alexander, Eva, Rothfuss, Oliver, Overkamp, Tim, Gillissen, Bernd, Daniel, Peter, Essmann, Frank

Volltext

Abstract 591: Host cell DNA damage and inflammation responses determine oncolytic adenovirus efficacy in ovarian cancer von Salako, Michael A., Connell, Claire M., Shibata, Atsushi, Graupner, Vilma, Lockley, Michelle, Balkwill, Frances R., McNeish, Iain A.

Volltext

Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53 von Graupner, Vilma, Schulze-Osthoff, Klaus, Essmann, Frank, Jänicke, Reiner U

Volltext

Funktionelle Charakterisierung neuer Isoformen des Tumorsuppressors p53

Volltext bestellen